Abstract
Objectives There was no consensus regarding the treatment of intracranial chondrosarcoma (CSA). The study aimed to evaluate the adverse factors for progression-free survival (PFS) and overall survival (OS), and propose a treatment strategy for CSA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have